Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Tablets Recalled for Foreign Substance
07/11/2024
The presence of a foreign substance has prompted Dr Reddy’s Laboratories Inc. to recall allopurinol tablets distributed in 3 states.
The presence of a foreign substance has prompted Dr Reddy’s Laboratories Inc. to recall allopurinol tablets distributed in 3 states.
The presence of a foreign...
07/11/2024
Pharmacy Learning Network

Advertisement

News
Insomnia Drug Recalled
07/11/2024
Dr Reddy’s Laboratories Inc. is recalling 13 752 bottles of eszopiclone tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 13 752 bottles of eszopiclone tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
07/11/2024
Pharmacy Learning Network
News
Class I Recall for Male Enhancement Supplements
07/11/2024
A Class I recall has been issued for Ram It and To The Moon capsules distributed by Integrity Products after an FDA analysis found the dietary supplements were tainted with sildenafil and tadalafil.
A Class I recall has been issued for Ram It and To The Moon capsules distributed by Integrity Products after an FDA analysis found the dietary supplements were tainted with sildenafil and tadalafil.
A Class I recall has been issued...
07/11/2024
Pharmacy Learning Network
News
New Methods for RSV Prevention and Detection Developed by Georgia State University
07/03/2024
Georgia State University researchers are developing new tools and technologies to improve treatment, prevention, and detection of respiratory syncytial virus (RSV), with potential applications in drug screening and vaccine development.
Georgia State University researchers are developing new tools and technologies to improve treatment, prevention, and detection of respiratory syncytial virus (RSV), with potential applications in drug screening and vaccine development.
Georgia State University...
07/03/2024
Pharmacy Learning Network

Advertisement

News
Pain Injections Recalled
07/03/2024
Central Admixture Pharmacy Services Inc. is recalling nearly 5000 hydromorphone injections because of a lack of assurance of sterility. Specifically, the injections lack validation data for sanitization cycles, according to recall...
Central Admixture Pharmacy Services Inc. is recalling nearly 5000 hydromorphone injections because of a lack of assurance of sterility. Specifically, the injections lack validation data for sanitization cycles, according to recall...
Central Admixture Pharmacy...
07/03/2024
Pharmacy Learning Network
News
Paralyzing Agent Recalled
07/03/2024
Some 2640 syringes containing vecuronium are being recalled by Central Admixture Pharmacy Services Inc. for sterility concerns. A recall announcement recently added to the US Food and Drug Administration (FDA) Enforcement Report website...
Some 2640 syringes containing vecuronium are being recalled by Central Admixture Pharmacy Services Inc. for sterility concerns. A recall announcement recently added to the US Food and Drug Administration (FDA) Enforcement Report website...
Some 2640 syringes containing...
07/03/2024
Pharmacy Learning Network
News
Sterility Concerns Prompt Recall of Opioid Analgesics
07/03/2024
Numerous fentanyl products are under a Class II recall because of a lack of assurance of sterility. According to recall announcements added to the US Food and Drug Administration (FDA) Enforcement Report website over the past week, the...
Numerous fentanyl products are under a Class II recall because of a lack of assurance of sterility. According to recall announcements added to the US Food and Drug Administration (FDA) Enforcement Report website over the past week, the...
Numerous fentanyl products are...
07/03/2024
Pharmacy Learning Network

Advertisement

News
Steroid Injection Recalled
06/27/2024
More than 70 000 vials of dexamethasone sodium phosphate injection are under recall for an impurity.
More than 70 000 vials of dexamethasone sodium phosphate injection are under recall for an impurity.
More than 70 000 vials of...
06/27/2024
Pharmacy Learning Network
News
Blood Thinner Recalled
06/27/2024
Eugia US is recalling 15 500 single-dose vials of eptifibatide injection.
Eugia US is recalling 15 500 single-dose vials of eptifibatide injection.
Eugia US is recalling 15 500...
06/27/2024
Pharmacy Learning Network
News
Corticosteroid Injection Recalled
06/19/2024
Pacira Pharmaceuticals Inc. is recalling 43 768 kits of Zilretta (triamcinolone acetonide extended-release injectable suspension) for failing stability testing.
Pacira Pharmaceuticals Inc. is recalling 43 768 kits of Zilretta (triamcinolone acetonide extended-release injectable suspension) for failing stability testing.
Pacira Pharmaceuticals Inc. is...
06/19/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use